110 related articles for article (PubMed ID: 27923566)
1. Flavonolignans inhibit ADP induced blood platelets activation and aggregation in whole blood.
Bijak M; Szelenberger R; Saluk J; Nowak P
Int J Biol Macromol; 2017 Feb; 95():682-688. PubMed ID: 27923566
[TBL] [Abstract][Full Text] [Related]
2. Inhibitory Effect of Flavonolignans on the P2Y12 Pathway in Blood Platelets.
Bijak M; Szelenberger R; Dziedzic A; Saluk-Bijak J
Molecules; 2018 Feb; 23(2):. PubMed ID: 29439388
[TBL] [Abstract][Full Text] [Related]
3. Flavonolignans inhibit the arachidonic acid pathway in blood platelets.
Bijak M; Saluk-Bijak J
BMC Complement Altern Med; 2017 Aug; 17(1):396. PubMed ID: 28797264
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the Cytotoxicity and Genotoxicity of Flavonolignans in Different Cellular Models.
Bijak M; Synowiec E; Sitarek P; Sliwiński T; Saluk-Bijak J
Nutrients; 2017 Dec; 9(12):. PubMed ID: 29240674
[TBL] [Abstract][Full Text] [Related]
5. [Flavonolignans - compounds not only for liver treatment].
Bijak M
Pol Merkur Lekarski; 2017 Jan; 42(247):34-37. PubMed ID: 28134230
[TBL] [Abstract][Full Text] [Related]
6. Flavonolignans reduce the response of blood platelet to collagen.
Bijak M; Dziedzic A; Saluk-Bijak J
Int J Biol Macromol; 2018 Jan; 106():878-884. PubMed ID: 28842200
[TBL] [Abstract][Full Text] [Related]
7. Flavonolignans Inhibit IL1-β-Induced Cross-Talk between Blood Platelets and Leukocytes.
Bijak M; Dziedzic A; Synowiec E; Sliwinski T; Saluk-Bijak J
Nutrients; 2017 Sep; 9(9):. PubMed ID: 28914761
[TBL] [Abstract][Full Text] [Related]
8. The Effect of Silymarin Flavonolignans and Their Sulfated Conjugates on Platelet Aggregation and Blood Vessels Ex Vivo.
Pourová J; Applová L; Macáková K; Vopršalová M; Migkos T; Bentanachs R; Biedermann D; Petrásková L; Tvrdý V; Hrubša M; Karlíčková J; Křen V; Valentová K; Mladěnka P
Nutrients; 2019 Sep; 11(10):. PubMed ID: 31554252
[TBL] [Abstract][Full Text] [Related]
9. The effect of milk thistle (Silybum marianum) and its main flavonolignans on CYP2C8 enzyme activity in human liver microsomes.
Albassam AA; Frye RF; Markowitz JS
Chem Biol Interact; 2017 Jun; 271():24-29. PubMed ID: 28457856
[TBL] [Abstract][Full Text] [Related]
10. Isorhapontigenin, a resveratrol analogue selectively inhibits ADP-stimulated platelet activation.
Ravishankar D; Albadawi DAI; Chaggar V; Patra PH; Williams HF; Salamah M; Vaiyapuri R; Dash PR; Patel K; Watson KA; Vaiyapuri S
Eur J Pharmacol; 2019 Nov; 862():172627. PubMed ID: 31461638
[TBL] [Abstract][Full Text] [Related]
11. The study of flavonolignan association patterns in fruits of diverging Silybum marianum (L.) Gaertn. chemotypes provides new insights into the silymarin biosynthetic pathway.
Martinelli T; Whittaker A; Benedettelli S; Carboni A; Andrzejewska J
Phytochemistry; 2017 Dec; 144():9-18. PubMed ID: 28863306
[TBL] [Abstract][Full Text] [Related]
12. Prostaglandin E1 potentiates the effects of P2Y12 blockade on ADP-mediated platelet aggregation in vitro: Insights using short thromboelastography.
Khanna V; Armstrong PC; Warner TD; Curzen N
Platelets; 2015; 26(7):689-92. PubMed ID: 25734957
[TBL] [Abstract][Full Text] [Related]
13. A complementary role for tetraspanin superfamily member CD151 and ADP purinergic P2Y12 receptor in platelets.
Makkawi M; Moheimani F; Alserihi R; Howells D; Wright M; Ashman L; Jackson DE
Thromb Haemost; 2015 Nov; 114(5):1004-19. PubMed ID: 26245294
[TBL] [Abstract][Full Text] [Related]
14. Comparison of VASP-phosphorylation assay to light-transmission aggregometry in assessing inhibition of the platelet ADP P2Y12 receptor.
Pampuch A; Cerletti C; de Gaetano G
Thromb Haemost; 2006 Dec; 96(6):767-73. PubMed ID: 17139371
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the aggregation responses of camel platelets.
Al Ghumlas AK; Gader AG
Vet Clin Pathol; 2013 Sep; 42(3):307-13. PubMed ID: 23919654
[TBL] [Abstract][Full Text] [Related]
16. Desensitization of the platelet aggregation response to ADP: differential down-regulation of the P2Y1 and P2cyc receptors.
Baurand A; Eckly A; Bari N; Léon C; Hechler B; Cazenave JP; Gachet C
Thromb Haemost; 2000 Sep; 84(3):484-91. PubMed ID: 11019976
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics and metabolic profile of free, conjugated, and total silymarin flavonolignans in human plasma after oral administration of milk thistle extract.
Wen Z; Dumas TE; Schrieber SJ; Hawke RL; Fried MW; Smith PC
Drug Metab Dispos; 2008 Jan; 36(1):65-72. PubMed ID: 17913795
[TBL] [Abstract][Full Text] [Related]
18. Recent advances in the analysis of flavonolignans of Silybum marianum.
Csupor D; Csorba A; Hohmann J
J Pharm Biomed Anal; 2016 Oct; 130():301-317. PubMed ID: 27321822
[TBL] [Abstract][Full Text] [Related]
19. Lidocaine priming reduces ADP-induced P-selectin expression and platelet-leukocyte aggregation.
Huang GS; Lin TC; Wang JY; Ku CH; Ho ST; Li CY
Acta Anaesthesiol Taiwan; 2009 Jun; 47(2):56-61. PubMed ID: 19527965
[TBL] [Abstract][Full Text] [Related]
20. Adenosine diphosphate-induced platelet aggregation is associated with P2Y12 gene sequence variations in healthy subjects.
Fontana P; Dupont A; Gandrille S; Bachelot-Loza C; Reny JL; Aiach M; Gaussem P
Circulation; 2003 Aug; 108(8):989-95. PubMed ID: 12912815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
